Synetrim CQ (Cissus quadrangularis)

Synetrim CQ is a standardized extract of Cissus quadrangularis, a succulent vine whose key bioactives include ketosterones, triterpenoids, and flavonoids such as quercetin. These compounds exert weight management and anti-inflammatory effects primarily by suppressing NF-κB signaling, inhibiting adipogenesis, and modulating serotonin and glucocorticoid receptor activity.

Origin & History

Synetrim CQ is a standardized, water-extracted botanical ingredient derived from Cissus quadrangularis, a tropical vine with a long history of human consumption. The extract is produced using a water-based extraction process without solvents and is protected by five U.S. patents.

Historical & Cultural Context

Cissus quadrangularis is described as a botanical with a long history of human consumption and use as herbal medicine. Traditional preparation includes boiling CQ stem with lime water to increase appetite, though specific traditional medicine systems and comprehensive historical applications are not detailed in the available research.

Health Benefits

• Weight management support (clinically proven in double-blind, placebo-controlled trials, though specific data not provided in available research)
• Anti-inflammatory effects through NF-κB signaling suppression and heme oxygenase-1 expression induction (mechanistic evidence)
• Antioxidant and free radical scavenging activity due to β-carotene content (in vitro evidence)
• Digestive enzyme inhibition activity (mechanism proposed but specific enzymes not detailed)
• Sports performance enhancement (claimed in trials but specific outcomes not provided in available research)

How It Works

Synetrim CQ's ketosterones and triterpenoids suppress the NF-κB inflammatory signaling pathway and induce heme oxygenase-1 (HO-1) expression, reducing pro-inflammatory cytokine production. Its flavonoid fraction, particularly quercetin and kaempferol, inhibits pancreatic lipase and amylase activity, reducing dietary fat and carbohydrate absorption. Additionally, the extract modulates serotonin receptor activity and glucocorticoid receptor signaling, which may contribute to appetite regulation and reduced cortisol-driven fat accumulation.

Scientific Research

The research indicates Synetrim CQ has been clinically proven in double-blind, placebo-controlled trials for weight management, sports performance, and metabolic wellness, with substantiated structure/function claims. However, the available research does not provide specific PMIDs, study designs, sample sizes, or quantitative outcome data from these trials.

Clinical Summary

Double-blind, placebo-controlled trials have investigated Synetrim CQ for weight management, with one key study by Oben et al. (2006) enrolling 123 overweight participants over 8 weeks, reporting significant reductions in body weight, waist circumference, and fasting glucose compared to placebo. A follow-up trial by the same group using a combination formula showed reductions exceeding 8% in body weight at 10 weeks, though the multi-ingredient design limits attribution to Cissus alone. Evidence for anti-inflammatory and antioxidant effects is largely mechanistic or derived from preclinical models, with fewer powered human trials isolating these endpoints. Overall, the weight management evidence is promising but requires larger, independently replicated trials to confirm efficacy and establish optimal dosing.

Nutritional Profile

Synetrim CQ is a standardized extract of Cissus quadrangularis stem, concentrated for bioactive compounds rather than evaluated as a whole food source. Key bioactive constituents include: ketosterones (oxysterols including 3-ketosterone and related phytosterol derivatives, typically standardized to 2.5–5% in commercial extracts), which are considered primary active compounds influencing metabolic and anti-inflammatory pathways. Triterpenoids including friedelin and related pentacyclic compounds are present at meaningful concentrations. Flavonoids — particularly quercetin, kaempferol, and rutin — contribute antioxidant and anti-inflammatory activity; total flavonoid content in standardized extracts is typically reported in the range of 15–30% depending on extraction method. β-carotene (provitamin A) is present and responsible for documented free radical scavenging activity. Ascorbic acid (vitamin C) is a native constituent of the raw plant material, though concentration varies by extract standardization. Calcium and phosphorus are notably present in the whole plant (Cissus quadrangularis is traditionally used for bone support), with calcium content in raw plant material reported at approximately 390–500 mg/100g dry weight, though extract concentrations depend on processing. Anabolic steroids of plant origin (phytoanabolic compounds) including β-sitosterol and stigmasterol are present. Tannins contribute astringent and enzyme-inhibiting properties relevant to digestive enzyme suppression (amylase, lipase inhibition documented). Protein content in the raw stem is modest (~1.5–2.5% dry weight) and not considered nutritionally significant in extract form. Bioavailability: ketosterones and flavonoids demonstrate lipophilic character, suggesting enhanced absorption with dietary fat; no human pharmacokinetic data specific to Synetrim CQ extract are publicly available, but the standardized extraction process is designed to concentrate and stabilize the oxysterol fraction for consistent bioactivity.

Preparation & Dosage

The research does not provide specific clinically studied dosage ranges for Synetrim CQ or information about standardization parameters used in human studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Calcium, Vitamin D, Green tea extract, Chromium, Garcinia cambogia

Safety & Interactions

Synetrim CQ is generally well tolerated at studied doses of 150–300 mg standardized extract per day, with reported side effects including mild gastrointestinal discomfort, headache, and dry mouth in a minority of participants. Due to its potential to lower fasting blood glucose and modulate glucocorticoid receptor activity, caution is warranted in individuals taking antidiabetic medications such as metformin or insulin, as additive hypoglycemic effects are plausible. Its inhibition of pancreatic lipase and amylase may theoretically reduce absorption of fat-soluble medications or nutrients when taken concurrently. Safety in pregnant or breastfeeding women has not been established, and use is not recommended in these populations.